Nirav Patel1, Ankur Gupta2, Rajkumar Doshi3, Rajat Kalra4, Navkaranbir S Bajaj1,2, Garima Arora1, Pankaj Arora1,5. 1. Division of Cardiovascular Disease, University of Alabama at Birmingham Birmingham, AL (N.P., N.S.B., G.A., P.A.). 2. Cardiovascular Division, Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (A.G., N.S.B.). 3. Department of Internal Medicine, Reno School of Medicine, University of Nevada, Reno, NV (R.D.). 4. Cardiovascular Division, University of Minnesota, Minneapolis, MN (R.K.). 5. Section of Cardiology, Birmingham Veterans Affairs Medical Center, AL (P.A.).
Abstract
BACKGROUND: Medicaid expansion among previously uninsured individuals has led to improved healthcare access. However, considerably lower reimbursement rates of Medicaid have raised concerns on the unintended consequence of lower utilization of life-saving therapies and inferior outcomes compared with private insurance. We examined the rates of revascularization and in-hospital mortality among Medicaid beneficiaries versus privately insured individuals hospitalized with ST-segment-elevation myocardial infarction (STEMI). METHODS AND RESULTS: We queried the National Inpatient Sample from 2012 to 2015 for STEMI hospitalizations with Medicaid or private insurance as primary payer. Hospitalizations with the following criteria were excluded: (1) age <18 or ≥65 years, (2) transfer to another acute care facility, and (3) left against medical advice. Outcomes were compared in propensity score-matched cohort based on demographics, socioeconomic status (income based), clinical comorbidities, including drug and alcohol use, STEMI acuity (cardiac arrest and cardiogenic shock), and hospital characteristics. A total of 42 645 and 171 545 STEMI hospitalizations were identified as having Medicaid and private insurance, respectively. In unadjusted analyses, Medicaid beneficiaries with STEMI had lower rates of coronary revascularization (88.9% versus 92.3%; odds ratio, 0.67; 95% CI, 0.65-0.70) and higher rates of in-hospital mortality (4.9% versus 2.8%; odds ratio, 1.81; 95% CI, 1.72-1.91) compared with privately insured individuals ( P<0.001 for both). In propensity-matched cohort of 40 870 hospitalizations per group, similar results for lower rates of revascularization (89.1% versus 91.1%; odds ratio, 0.80; 95% CI, 0.76-0.84) and higher in-hospital mortality (4.9% versus 3.7%; odds ratio, 1.35; 95% CI, 1.26-1.45) were observed in Medicaid compared with private insurance, despite extensive matching ( P<0.001 for both). CONCLUSIONS: Medicaid beneficiaries with STEMI had lower rates of revascularization, although small absolute difference, and higher in-hospital mortality compared with privately insured individuals. Further studies are needed to identify and understand the variation in STEMI outcomes by insurance status.
BACKGROUND: Medicaid expansion among previously uninsured individuals has led to improved healthcare access. However, considerably lower reimbursement rates of Medicaid have raised concerns on the unintended consequence of lower utilization of life-saving therapies and inferior outcomes compared with private insurance. We examined the rates of revascularization and in-hospital mortality among Medicaid beneficiaries versus privately insured individuals hospitalized with ST-segment-elevation myocardial infarction (STEMI). METHODS AND RESULTS: We queried the National Inpatient Sample from 2012 to 2015 for STEMI hospitalizations with Medicaid or private insurance as primary payer. Hospitalizations with the following criteria were excluded: (1) age <18 or ≥65 years, (2) transfer to another acute care facility, and (3) left against medical advice. Outcomes were compared in propensity score-matched cohort based on demographics, socioeconomic status (income based), clinical comorbidities, including drug and alcohol use, STEMI acuity (cardiac arrest and cardiogenic shock), and hospital characteristics. A total of 42 645 and 171 545 STEMI hospitalizations were identified as having Medicaid and private insurance, respectively. In unadjusted analyses, Medicaid beneficiaries with STEMI had lower rates of coronary revascularization (88.9% versus 92.3%; odds ratio, 0.67; 95% CI, 0.65-0.70) and higher rates of in-hospital mortality (4.9% versus 2.8%; odds ratio, 1.81; 95% CI, 1.72-1.91) compared with privately insured individuals ( P<0.001 for both). In propensity-matched cohort of 40 870 hospitalizations per group, similar results for lower rates of revascularization (89.1% versus 91.1%; odds ratio, 0.80; 95% CI, 0.76-0.84) and higher in-hospital mortality (4.9% versus 3.7%; odds ratio, 1.35; 95% CI, 1.26-1.45) were observed in Medicaid compared with private insurance, despite extensive matching ( P<0.001 for both). CONCLUSIONS: Medicaid beneficiaries with STEMI had lower rates of revascularization, although small absolute difference, and higher in-hospital mortality compared with privately insured individuals. Further studies are needed to identify and understand the variation in STEMI outcomes by insurance status.
Entities:
Keywords:
Medicaid; ST elevation myocardial infarction; hospitals; humans; inpatients
Authors: Michael A Gaglia; Rebecca Torguson; Zhenyi Xue; Manuel A Gonzalez; Sara D Collins; Itsik Ben-Dor; Asmir I Syed; Gabriel Maluenda; Cedric Delhaye; Nicholas Hanna; Kohei Wakabayashi; Kimberly Kaneshige; William O Suddath; Kenneth M Kent; Lowell F Satler; Augusto D Pichard; Ron Waksman Journal: JACC Cardiovasc Interv Date: 2010-07 Impact factor: 11.195
Authors: Eric I Benchimol; Liam Smeeth; Astrid Guttmann; Katie Harron; David Moher; Irene Petersen; Henrik T Sørensen; Erik von Elm; Sinéad M Langan Journal: PLoS Med Date: 2015-10-06 Impact factor: 11.069
Authors: Saraschandra Vallabhajosyula; Sri Harsha Patlolla; Shannon M Dunlay; Abhiram Prasad; Malcolm R Bell; Allan S Jaffe; Bernard J Gersh; Charanjit S Rihal; David R Holmes; Gregory W Barsness Journal: Circ Heart Fail Date: 2020-02-14 Impact factor: 8.790
Authors: Saraschandra Vallabhajosyula; Viral K Desai; Pranathi R Sundaragiri; Wisit Cheungpasitporn; Rajkumar Doshi; Vikas Singh; Allan S Jaffe; Amir Lerman; Gregory W Barsness Journal: Ann Transl Med Date: 2021-07
Authors: Vinay Kini; Bridget Mosley; Sridharan Raghavan; Prateeti Khazanie; Steven M Bradley; David J Magid; P Michael Ho; Frederick A Masoudi Journal: J Am Heart Assoc Date: 2021-01-28 Impact factor: 5.501
Authors: Saraschandra Vallabhajosyula; Vinayak Kumar; Pranathi R Sundaragiri; Wisit Cheungpasitporn; Malcolm R Bell; Mandeep Singh; Allan S Jaffe; Gregory W Barsness Journal: PLoS One Date: 2020-12-18 Impact factor: 3.240
Authors: Saraschandra Vallabhajosyula; Aditi Shankar; Sri Harsha Patlolla; Abhiram Prasad; Malcolm R Bell; Jacob C Jentzer; Shilpkumar Arora; Saarwaani Vallabhajosyula; Bernard J Gersh; Allan S Jaffe; David R Holmes; Shannon M Dunlay; Gregory W Barsness Journal: ESC Heart Fail Date: 2020-04-02